Back to search results

Healthy Aging for Black Adults with Chronic Pain and Cognitive Decline

This study is for Black adults, aged 50 and older, who experience chronic pain and early memory problems. It compares two programs: Mindfulness-Based Cognitive Therapy with Walking (MBCT+w) and Active Living Every Day (ALED). MBCT+w teaches skills to manage pain and cognitive concerns, while ALED helps you become more physically active. Researchers want to see if these programs improve your physical, mental, and emotional well-being. They will measure your physical function at the start, after 12 weeks, and again at 6 months to see how well the programs work and if the benefits last. The study aims to enroll 400 participants.

Study design
This is a randomized controlled trial comparing two programs. It plans to enroll 400 participants.
What's involved
You would participate in either an 8-session program (MBCT+w, 90 minutes per session) or a 12-session program (ALED, 60 minutes per session). Outcomes will be assessed at the beginning, after the program, and 6 months later.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 6 months after the program ends.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06246929

Healthy Aging as Black Adults, In It Together: a Comparative Effectiveness Study of Chronic Pain and Cognitive Decline

Recruiting
NAAges 50+InterventionalTreatment
Massachusetts General Hospital
~400 participants
Updated 2026-07-07 on ClinicalTrials.gov
What's tested:MBCT+wALED

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient Reported Outcomes Measurement Information System (PROMIS) Physical Function
Measured over 0 Weeks, 12 Weeks, 6 Months

Conditions

Chronic Pain
Physical Activity
Older Adults
Mild Cognitive Impairment

Explore related trials

Chronic PainMild cognitive disorder

Where it's being run

1 sites across 1 states
Massachusetts1

Study leadership

  • Olivia Okereke, MD, MS · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital

Who to contact

Mallory Morehead, MPH
[email protected]
(978) 580-3153
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Black adults, male and females, age 50 or older
Have nonmalignant musculoskeletal chronic pain for more than three months
Reports early cognitive decline (subjective and objective)
Telephone Interview for Cognitive Status-41 score greater than or equal to 31
Functional Activities Questionnaire score less than 9
English fluency/literacy
Free of concurrent psychotropic or pain medication for at least 2 weeks prior to initiation of treatment, OR stable on current psychotropic or pain medication for a minimum of 6 weeks and willing to maintain stable dose
Cleared by medical doctor for study participation and no self-reported concerns about physical functioning on the revised Physical Activity Readiness Questionnaire (PAR-Q; score 0)

Exclusion

Diagnosed with dementia or neurodegenerative disease
Regular use of nonpharmacological pain management
Diagnosed with serious mental illness or substance abuse
Current suicidal ideation on self-report
Engagement of regular exercise for more than 30 minutes daily
Unable to walk

What this trial measures

  • Patient Reported Outcomes Measurement Information System (PROMIS) Physical Function0 Weeks, 12 Weeks, 6 Months

    Change in participant's self-reported performance of everyday physical activities, with items ranging from 1-4. Higher T scores indicate greater physical function.